PHASE-II EVALUATION OF DIANHYDROGALACTITOL IN THE TREATMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

被引：0
|
作者：
STEHMAN, FB
BLESSING, JA
DELGADO, G
LOUKA, M
机构：
[1] THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,GYNECOL ONCOL GRP,HEADQUARTERS OFF,PHILADELPHIA,PA 19107
[2] GEORGETOWN UNIV HOSP,WASHINGTON,DC 20007
[3] HAHNEMANN MED COLL & HOSP,PHILADELPHIA,PA 19102
[4] INDIANA UNIV,MED CTR,INDIANAPOLIS,IN 46204
[5] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,BUFFALO,NY 14263
来源：
CANCER TREATMENT REPORTS | 1983年 / 67卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：737 / 738
页数：2
相关论文
共 50 条
  • [31] ECHINOMYCIN (NSC-526417) IN ADVANCED OVARIAN-CANCER - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    MUSS, HB
    BLESSING, JA
    BAKER, VV
    BARNHILL, DR
    ADELSON, MD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (04): : 299 - 301
  • [32] PHASE-II TRIAL OF AMSA IN PATIENTS WITH ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    BONOMI, P
    BLESSING, JA
    SEDLACEK, TV
    HOMESLEY, HD
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1983, 67 (02): : 197 - 198
  • [33] A PHASE-II TRIAL OF EDATREXATE IN PREVIOUSLY TREATED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    BROUN, ER
    ISEMINGER, KA
    BOOKMAN, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02): : 164 - 166
  • [34] CISPLATIN AS 2ND-LINE CHEMOTHERAPY IN THE TREATMENT OF ADVANCED OR RECURRENT LEIOMYOSARCOMA OF THE UTERUS - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    THIGPEN, JT
    BLESSING, JA
    WILBANKS, GD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 18 - 20
  • [35] PHASE-II EVALUATION OF DIANHYDROGALACTITOL IN LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    HAAS, CD
    BAKER, L
    THIGPEN, T
    CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 115 - 117
  • [36] PHASE-II TRIAL OF PIPERAZINEDIONE (NCS135758) IN THE TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, J
    HOMESLEY, HD
    ADCOCK, LL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 423 - 426
  • [37] A PHASE-II CLINICAL-TRIAL OF DIAZIQUONE (AZQ) IN THE TREATMENT OF PATIENTS WITH RECURRENT LEIOMYOSARCOMA OF THE UTERUS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    LOOK, K
    ANDERSON, B
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (02) : 207 - 208
  • [38] PHASE-II CLINICAL-TRIAL OF DIAZIQUONE IN THE TREATMENT OF PATIENTS WITH EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    SLAYTON, RE
    BLESSING, JA
    SUTTON, GP
    HOMESLEY, HD
    PARK, R
    CANCER TREATMENT REPORTS, 1986, 70 (02): : 309 - 310
  • [39] A PHASE-II TRIAL OF TRICYCLIC NUCLEOSIDE PHOSPHATE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    FEUN, LG
    BLESSING, JA
    BARRETT, RJ
    HANJANI, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 506 - 508
  • [40] THE PROGNOSTIC VALUE OF NUCLEAR VERSUS ARCHITECTURAL GRADING IN ENDOMETRIAL ADENOCARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    ZAINO, RJ
    SILVERBERG, SG
    NORRIS, HJ
    BUNDY, BN
    MORROW, CP
    OKAGAKI, T
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1994, 13 (01) : 29 - 36
12345